{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:57:49Z","timestamp":1763535469900},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/md.0000000000007700","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T20:09:21Z","timestamp":1501618161000},"page":"e7700","source":"Crossref","is-referenced-by-count":19,"title":["Serum 25-hydroxyvitamin D might be an independent prognostic factor for Graves disease recurrence"],"prefix":"10.1097","volume":"96","author":[{"given":"Hwa Young","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Jae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-40-20210226","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","article-title":"Vitamin D and multiple sclerosis","volume":"9","author":"Ascherio","year":"2010","journal-title":"Lancet Neurol"},{"key":"R2-40-20210226","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pbiomolbio.2006.02.020","article-title":"Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease","volume":"92","author":"Cantorna","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"key":"R3-40-20210226","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/art.11434","article-title":"Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study","volume":"50","author":"Merlino","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R4-40-20210226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","article-title":"Vitamin D deficiency in systemic lupus erythematosus","volume":"5","author":"Kamen","year":"2006","journal-title":"Autoimmun Rev"},{"key":"R5-40-20210226","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study","volume":"358","author":"Hypponen","year":"2001","journal-title":"Lancet"},{"key":"R6-40-20210226","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/cmi.2010.73","article-title":"Vitamin D and autoimmune thyroid diseases","volume":"8","author":"Kivity","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"R7-40-20210226","doi-asserted-by":"crossref","first-page":"e1639","DOI":"10.1097\/MD.0000000000001639","article-title":"Lower serum 25-hydroxyvitamin D level is associated with 3 types of autoimmune thyroid diseases","volume":"94","author":"Ma","year":"2015","journal-title":"Medicine"},{"key":"R8-40-20210226","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4158\/EP12376.OR","article-title":"The association between severity of vitamin D deficiency and Hashimoto's thyroiditis","volume":"19","author":"Bozkurt","year":"2013","journal-title":"Endocr Pract"},{"key":"R9-40-20210226","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/thy.2013.0460","article-title":"Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women","volume":"24","author":"Choi","year":"2014","journal-title":"Thyroid"},{"key":"R10-40-20210226","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s12020-012-9679-y","article-title":"Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves\u2019 disease","volume":"42","author":"Yasuda","year":"2012","journal-title":"Endocrine"},{"key":"R11-40-20210226","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12020-012-9789-6","article-title":"Serum vitamin D levels are decreased in patients without remission of Graves\u2019 disease","volume":"43","author":"Yasuda","year":"2013","journal-title":"Endocrine"},{"key":"R12-40-20210226","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4158\/EP14191.OR","article-title":"Low vitamin D status is associated with increased thyrotropin-receptor antibody titer in Graves\u2019 disease","volume":"21","author":"Zhang","year":"2015","journal-title":"Endocr Pract"},{"key":"R13-40-20210226","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-121-4-199408150-00010","article-title":"Treatment of hyperthyroid disease","volume":"121","author":"Klein","year":"1994","journal-title":"Ann Intern Med"},{"key":"R14-40-20210226","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-40-20210226","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves\u2019 disease in Europe, Japan, and the United States","volume":"1","author":"Wartofsky","year":"1991","journal-title":"Thyroid"},{"key":"R16-40-20210226","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3803\/EnM.2013.28.4.275","article-title":"The diagnosis and management of hyperthyroidism in Korea: consensus report of the Korean thyroid association","volume":"28","author":"Moon","year":"2013","journal-title":"Endocrinol Metab"},{"key":"R17-40-20210226","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.1.01993","article-title":"A systematic review of drug therapy for Graves\u2019 hyperthyroidism","volume":"153","author":"Abraham","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R18-40-20210226","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R19-40-20210226","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1089\/thy.1999.9.1069","article-title":"Validation of ultrasonography of the thyroid gland for epidemiological purposes","volume":"9","author":"Knudsen","year":"1999","journal-title":"Thyroid"},{"key":"R20-40-20210226","first-page":"3","article-title":"Maximally selected rank statistics in R","volume":"2","author":"Hothorn","year":"2002","journal-title":"R News"},{"key":"R21-40-20210226","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1089\/thy.2014.0090","article-title":"Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer","volume":"24","author":"Kim","year":"2014","journal-title":"Thyroid"},{"key":"R22-40-20210226","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/en.2008-1191","article-title":"Vitamin D deficiency modulates Graves\u2019 hyperthyroidism induced in BALB\/c mice by thyrotropin receptor immunization","volume":"150","author":"Misharin","year":"2009","journal-title":"Endocrinology"},{"key":"R23-40-20210226","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0026-0495(97)90214-6","article-title":"Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves\u2019 disease","volume":"46","author":"Kawakami-Tani","year":"1997","journal-title":"Metabolism"},{"key":"R24-40-20210226","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-012-9776-y","article-title":"Vitamin D deficiency in patients with Graves\u2019 disease: probably something more than a casual association","volume":"43","author":"Rotondi","year":"2013","journal-title":"Endocrine"},{"key":"R25-40-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2008-1454","article-title":"Nonclassic actions of vitamin D","volume":"94","author":"Bikle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-40-20210226","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.autrev.2011.05.002","article-title":"Effects of vitamin D on the peripheral adaptive immune system: a review","volume":"10","author":"Peelen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R27-40-20210226","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"1,25-dihydroxyvitamin D3 receptors in human leukocytes","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science"},{"key":"R28-40-20210226","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1alpha,25-dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-40-20210226","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","article-title":"Vitamin D: modulator of the immune system","volume":"10","author":"Baeke","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"R30-40-20210226","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"R31-40-20210226","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1172\/JCI114768","article-title":"Thyroid-stimulating antibody activity between different immunoglobulin G subclasses","volume":"86","author":"Weetman","year":"1990","journal-title":"J Clin Invest"},{"key":"R32-40-20210226","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1530\/acta.0.1200689","article-title":"Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves\u2019 disease","volume":"120","author":"Schleusener","year":"1989","journal-title":"Acta Endocrinol"},{"key":"R33-40-20210226","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1470583","article-title":"Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves\u2019 disease","volume":"147","author":"Nedrebo","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"R34-40-20210226","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2008.03413.x","article-title":"Vitamin D receptor (VDR) gene polymorphisms and Graves\u2019 disease: a meta-analysis","volume":"70","author":"Zhou","year":"2009","journal-title":"Clin Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:56:29Z","timestamp":1620960989000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201708040-00040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007700","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}